LifeMD Adds Mail-Order Option for Lilly’s Zepbound and Foundayo
Photo: TokenPost
LifeMD, Inc. announced Nov. 5 a mail-order option for Eli Lilly and Company’s Zepbound and Foundayo, giving eligible patients a way to receive the medicines directly. Patients qualify only if a LifeMD-affiliated health care provider prescribes a medicine after an independent clinical evaluation. The medicines are dispensed through a LifeMD-affiliated, licensed mail-order pharmacy. Purchases are cash-pay at Lilly’s self-pay price. Zepbound contains tirzepatide and is an injectable treatment; Foundayo contains orforglipron and is a pill. John Kim reports on the digital-asset business for TokenPost. Send corrections or tips to info@tokenpost.com.
Source: TokenPost
